Treatment of tumor cells with CEA-TCB in the absence of immune cells did not lead to PD-L1 upregulation on tumor cells, further confirming the key role of activated immune cells in secreting IFNγ (Supplementary Figures 8B, C). Here, CEACAM5 is linked to neoplasm.